Kintara Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

TuHURA Biosciences

15/11/2021 22:01

* Kintara Therapeutics Inc  KTRA.OQ  reported a quarterly
adjusted loss of 17 cents​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of 14 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Kintara Therapeutics Inc's reported EPS for the quarter was a
loss of 25 cents​.
* The mean earnings estimate of analysts had risen by about 31%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Kintara Therapeutics Inc shares had risen by 3.9% this
quarter and lost 30.2% so far this year.
* The company reported a quarterly loss of $8.43 million.
* Wall Street's median 12-month price target for Kintara
Therapeutics Inc is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 10:01 p.m.
 ​All figures in US dollars unless otherwise stated